TP53 and neoplasm: Available data suggest that restoration of p53 via gene therapy alters the expression of a number of immunogenic markers on the surface of tumor cells and induces immunogenic cell death to render tumors more immunologically “hot”, i.e., responsive to immunotherapy (see Figure 1, middle panel) [27,28,29,30,31].